GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer
Recruiting · NCT05415007 · Interventional (participants receive a specific treatment) · Lead sponsor: Stanford University
View the official record on ClinicalTrials.gov →Interventions studied
GOLD ProgramTreatment as usual (TAU)
What this trial is about
The purpose of this study is to examine a psychotherapeutic and psycho-educational intervention offered in virtual settings to caregivers of youth with cancer. Human subjects must be used because they are the object of the intervention.
Who can take part
Age range
8 Years to 18 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Eligibility criteria (as published)
Inclusion and Exclusion Criteria: Parents
Inclusion
* Child (0-17yrs) with recent (\<12 mo) cancer diagnosis
* Fluent in English
* Consent to research
Exclusion:
* Lack of proficiency in written and spoken English
* Parent is under age 18
* Active Suicidal Ideation
* Child with cancer does not provide assent
Inclusion and Exclusion Criteria: Children
Inclusion:
* Recent (\<12 mo) cancer diagnosis in child
* 8-17 Years old
* Provides assent to participate in the study
Exclusion:
* Cannot read English
* Parent is not enrolled in the study
Anyone who is not a caregiver of children who have been diagnosed with cancer within the past 12 months will be excluded.
Where it is running
1 location listed across 1 US state.
- Stanford Cancer Institute - San Francisco, California, United States